Form 8-K - Current report:
SEC Accession No. 0001493152-25-009075
Filing Date
2025-03-04
Accepted
2025-03-04 17:28:10
Documents
14
Period of Report
2025-03-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36578
2 ex99-1.htm EX-99.1 11749
  Complete submission text file 0001493152-25-009075.txt   223283

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hepa-20250304.xsd EX-101.SCH 3027
4 XBRL LABEL FILE hepa-20250304_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE hepa-20250304_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3696
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 25706679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)